Form 4: Intuitive Surgical VP Controller Reports Stock Transactions

Intuitive Surgical's VP Corporate Controller, Fredrik Widman, reported multiple transactions involving common stock and Restricted Stock Units, including sales under a 10b5-1 plan.

Summary

• Fredrik Widman, VP Corporate Controller of Intuitive Surgical Inc., reported several transactions involving the company's common stock and Restricted Stock Units (RSUs).
• On February 27, 2026, Widman sold 249 shares of common stock at a price of $499.71 per share.
• On February 28, 2026, 468 Restricted Stock Units (RSUs) vested and converted into common stock at a price of $0.0.
• Concurrently on February 28, 2026, 233 shares were disposed of at $503.51 per share to cover statutory tax withholding requirements related to the RSU vesting.
• On March 3, 2026, an additional 118 shares of common stock were sold at a price of $487.18 per share.
• All sales transactions (Code S) were conducted under a Rule 10b5-1 trading plan, which is set to expire on May 21, 2026.
• Following these reported transactions, Widman beneficially owns 1,026 shares of common stock directly.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing. While there are sales, they are part of a pre-arranged plan and RSU vesting, which is a routine compensation event for executives, not signaling a negative outlook.

Positives

• The vesting of 468 Restricted Stock Units indicates continued compensation and retention of a key executive.
• The sales transactions were conducted under a pre-arranged Rule 10b5-1 trading plan, suggesting planned liquidity management rather than a reaction to new negative company information.

Negatives

• The sale of 249 shares at $499.71 and 118 shares at $487.18 represents a reduction in the direct beneficial ownership of common stock by the VP Corporate Controller.
• A portion of the vested shares (233 shares) was withheld to cover tax liabilities, reducing the net shares received from the RSU conversion.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider transactions, particularly sales, are common for executives managing their personal portfolios, especially when tied to RSU vesting and pre-arranged 10b5-1 plans. In the high-growth surgical robotics sector, executives often hold significant equity, and such planned sales are a routine part of compensation management, not necessarily indicative of a change in company fundamentals or outlook.

Stakeholder Impact

• Shareholders: Minor impact as these are routine insider transactions, potentially signaling executive confidence through RSU vesting, balanced by planned sales.
• Employees: No direct impact mentioned.

Key Dates

Recommendation

The filing details routine insider transactions, including RSU vesting and pre-planned sales under a 10b5-1 plan. These actions are typical for executives managing their personal finances and compensation, and do not provide new fundamental information to warrant a change in investment thesis. Therefore, a 'hold' recommendation is appropriate as the filing does not present significant new positive or negative catalysts.

Keywords

Intuitive Surgical, ISRG, Form 4, Insider Trading, Stock Transactions, Fredrik Widman, VP Corporate Controller, Restricted Stock Units, RSU Vesting, 10b5-1 Plan, Medical Devices, Surgical Robotics